In the present work, we convincingly showed that simultaneous targeting of both VEGF and EGFR could further suppress the proliferation and invasion of CRC cells in vitro, and further inhibit CRC cell tumor growth and angiogenesis through downregulation of AKT and ERK signaling in vivo. This evidence concerns the gene VEGFA and colorectal carcinoma.